Oriol Juanola
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Alcohol consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): understanding the gut-liver crosstalk for clinical translation.
Journal: Gut microbes
Published: February 21, 2026
Epigenetic reprogramming of hepatic antigen presenting cells in chronic liver disease.
Journal: Frontiers in immunology
Published: January 08, 2026
Epigenetic drug control of Clec4g/LSECtin expression reduces fibrosis burden in cirrhosis.
Journal: Hepatology communications
Published: November 08, 2025
Antagonizing epigenetically controlled PAF/PAF-R pathway improves liver function during experimental cirrhosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 19, 2025
LSECtin attenuates hepatic Th17 expansion in a murine model of cirrhosis and signals through the LAG-3 receptor.
Journal: JHEP reports : innovation in hepatology
Published: January 19, 2025
Aging Deteriorates Blood Brain Barrier Function and Polarizes Adaptive T Cell Expansion Contributing to Neurocognitive Damage in Experimental Cirrhosis.
Journal: Aging and disease
Published: August 02, 2024
Peripheral blood regulatory T cells and disease activity, quality of life, and outcomes in children with juvenile idiopathic arthritis.
Journal: Pediatric rheumatology online journal
Published: May 13, 2024
The mixed effect of Endocrine-Disrupting chemicals on biological age Acceleration: Unveiling the mechanism and potential intervention target.
Journal: Environment international
Published: June 20, 2023
Absence of gut microbiota impairs depletion of Paneth cells but not goblet cells in germ-free Atoh1lox/lox VilCreERT2 mice.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: March 21, 2023
Last Updated: 09/26/2026